Bone loss during neoadjuvant/adjuvant chemotherapy for�early stage breast cancer: A retrospective cohort study (original) (raw)

Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients

Julian Esparza-Romero

BMC Cancer, 2016

View PDFchevron_right

Does adjuvant chemotherapy change bone mineral density and related serum biomarkers in women with breast cancer

Caspian Journal of Internal Medicine (CJIM)

Caspian Journal of Internal Medicine, 2017

View PDFchevron_right

The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer

Ute-susann Albert

European Journal of Cancer, 2009

View PDFchevron_right

Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer

Tamsen Bassford

Cancer, 2005

View PDFchevron_right

Osteoporosis and Rate of Bone Loss among Postmenopausal Survivors of Breast Cancer: Results from a Subgroup in the Women’s Health Initiative Observational Study

Tamsen Bassford

Cancer

View PDFchevron_right

The Effect of Tamoxifen or Exemestane on Bone Mineral Density During the First 2 Years of Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer

Devchand Paul

Clinical Breast Cancer, 2008

View PDFchevron_right

Osteoporosis in women with breast cancer and its effect on quality of life: a pilot study

Omur Karakoyun Celik

Journal of B.U.ON. : official journal of the Balkan Union of Oncology

View PDFchevron_right

Effect of Adjuvant (Hormonal) Therapy on Bone Mineral Density in Caucasian Women with Breast Cancer

European Scientific Journal ESJ

View PDFchevron_right

Maintaining Bone Density in Patients Undergoing Treatment for Breast Cancer: Is There an Adjuvant Benefit?

Richard Greil

Clinical Breast Cancer, 2009

View PDFchevron_right

Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study

Julien Paccou

Annals of Oncology, 2014

View PDFchevron_right

Alteration of bone mineral density in breast cancer female survivors on chemotherapy treatment: an integrative review

Sara Socorro Faria

Revista Brasileira de Mastologia, 2017

View PDFchevron_right

Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer

Tetsuya Taguchi

Medicine, 2019

View PDFchevron_right

French recommendations on strategies for preventing and treating osteoporosis induced by adjuvant breast cancer therapies

Anna Schw

Joint Bone Spine, 2019

View PDFchevron_right

Skeletal health in breast cancer survivors

Pierre Bergmann

Maturitas, 2017

View PDFchevron_right

Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group

Anthony Howell

Cancer Treatment Reviews, 2008

View PDFchevron_right

BOne HEalth ManagEment in Patients with Early Breast Cancer: A Retrospective Italian Osteoncology Center “Real-Life” Experience (BOHEME Study)

Lorena Gurrieri

Journal of Clinical Medicine, 2019

View PDFchevron_right

Osteoporosis management in patients with breast cancer: EMAS position statement

Levent M. Senturk

Maturitas, 2017

View PDFchevron_right

Prevention and Treatment of Osteoporosis in Women With Breast Cancer

Farook Al-Azzawi

Mayo Clinic Proceedings, 2000

View PDFchevron_right

Current and emerging treatment strategies for breast cancer-induced bone loss

lotfi hacein-bey

Breast Cancer: Targets and Therapy, 2010

View PDFchevron_right

Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan

Yasuo Miyoshi

Cancer Letters, 2002

View PDFchevron_right

Cancer treatment–related bone loss: a review and synthesis of the literature

Aliya Khan

Current Oncology

View PDFchevron_right

Bone mineral density in postmenopausal women with breast cancer and the effect of tamoxifen

Evangelos Georgiou

Breast, 1994

View PDFchevron_right

High Bone Mineral Density of the Lumbar Spine Is Positively Associated with Breast Cancer

Jordana Carolina Marques Godinho Mota

BioMed Research International

View PDFchevron_right

Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)

Anita Giobbie-hurder

Annals of Oncology, 2011

View PDFchevron_right

Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study

Frances Milat

International Journal of Cancer, 2019

View PDFchevron_right

Cancer Treatment-Induced Bone Loss in women with breast cancer

Sana Idrees

BoneKEy Reports, 2015

View PDFchevron_right

Studies of Osteoporosis in Cancer Patients in Slovakia – Experience from Single Institute

Beata Spanikova

2012

View PDFchevron_right

Reduced bone density at completion of chemotherapy for a malignancy

Jorma Komulainen

Archives of Disease in Childhood, 1999

View PDFchevron_right

Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort study

David Geffen

NPJ breast cancer, 2022

View PDFchevron_right

Cancer Therapy Associated Bone Loss: Implications for Hip Fractures in Mid-Life Women with Breast Cancer

Athena Samaras

Clinical Cancer Research, 2011

View PDFchevron_right

Breast cancer survivors are at an increased risk for osteoporotic fractures not explained by lower BMD: a retrospective analysis

David Geffen

npj Breast Cancer, 2015

View PDFchevron_right

Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial

Weiping Chu

The Journal of Steroid Biochemistry and Molecular Biology, 2011

View PDFchevron_right

Bone health issues in breast cancer survivors: A Medicare Current Beneficiary Survey (MCBS) study

Luke Peppone, Karen Mustian

Supportive Care in Cancer, 2014

View PDFchevron_right

Prevalence of Secondary Causes of Bone Loss Among Breast Cancer Patients With Osteopenia and Osteoporosis

Jose Luis Camacho Diaz

Journal of Clinical Oncology, 2008

View PDFchevron_right

Elevated Bone Turnover Predicts for Bone Metastasis in Postmenopausal Breast Cancer: Results of NCIC CTG MA.14

Laurence Demers

Journal of Clinical Oncology, 2011

View PDFchevron_right